CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $3.22M invested in Cellectar Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.33% more ownership

Funds ownership: 0.35% → 0.67% (+0.33%)

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.3M
2
+$504K
3
+$284K
4
Renaissance Technologies
Renaissance Technologies
New York
+$49.7K
5
Citadel Advisors
Citadel Advisors
Florida
+$31.9K

Top Sellers

1
-$34K
2
-$1K
3
-$154
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.59M
2
$576K
3
$300K
4
$284K
5
$97.5K
6
$82K
7
$80K
8
$42.8K
9
$31.9K
10
$26.9K
11
$25.6K
12
$20.6K
13
$20.5K
14
$17.7K
15
$13K
16
$2.82K
17
$1K
18
$1K
19
$487
20
$239
21
$94
22
$68
23
$34
24
$31
25
–
1
2